Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study by Roper NA et al.
Excess mortality in a population with diabetes and the
impact of material deprivation: longitudinal, population
based study
Nick A Roper, Rudy W Bilous, William F Kelly, Nigel C Unwin, Vincent M Connolly
Abstract
Objectives To establish the age and sex specific
mortality for people with diabetes in comparison with
local and national background populations; to
investigate the relationship between mortality and
material deprivation in an unselected population with
diabetes.
Design Longitudinal study, using a population based
district diabetes register.
Setting South Tees, United Kingdom.
Participants All people known to have diabetes living
in Middlesbrough and Redcar and Cleveland local
authorities on 1 January 1994.
Main outcome measure Death, from any cause,
between 1 January 1994 and 31 December 1999.
Results Over the six years of the study 1205 (24.9%)
of 4842 participants died. All cause standardised
mortality ratios for type 1 diabetes were 641 (95%
confidence interval 406 to 962) in women and 294
(200 to 418) in men, and those for type 2 diabetes
were 160 (147 to 174) in women and 141 (130 to 152)
in men. Cause specific standardised mortality ratios
were increased for ischaemic heart disease,
cerebrovascular disease, and renal disease; no
reductions in mortality from other causes were seen.
The risk of premature death increased significantly
with increasing material deprivation (P < 0.001).
Conclusions Diabetes is associated with excess
mortality, even in an area with high background death
rates from cardiovascular disease. This excess
mortality is evident in all age groups, most
pronounced in young people with type 1 diabetes,
and exacerbated by material deprivation. Aggressive
approaches to the management of cardiovascular risk
factors could reduce the excess mortality in people
with diabetes.
Introduction
Diabetes mellitus is known to be underreported on
death certificates and hence underestimated by
national mortality statistics.1 2 People with diabetes
have been shown to have higher mortality than people
without diabetes, but mortality varies depending on the
location and the specific group studied.1–4 Mortality
studies of unselected populations with diabetes have
been performed in North America and Scandinavia.2 3
However, there is a paucity of British data referring to
unselected populations and none from the north of
England, an area with high mortality partly owing to
higher levels of material deprivation.5 British studies of
people with diabetes have shown increasing exposure
to cardiovascular risk factors with worsening material
deprivation,6–8 and data from people aged over 75 in
the United Kingdom are unclear with regard to excess
mortality and its possible causes.1 9 10
Our study compared the mortality in people with
known diabetes living in South Tees with the mortality
of the population of England and Wales and the local
population without diabetes. It also examined the rela›
tion between mortality and material deprivation in the
population with diabetes.
Methods
The area administered by Middlesbrough and Redcar
and Cleveland local authorities, referred to here as
South Tees, had a population of 290 000 in 1994. This
area has high unemployment, and mortality is above
the national average.11 Migration rates in the area are
low: during the study less than 3% of the cohort regis›
tered outside Tees Health Authority.
Participants
The cohort was derived from the South Tees district
diabetes register and comprised all diabetic patients
with an address in South Tees who were alive on 1
January 1994. The diabetes register is maintained by
full time staff and contains demographic and clinical
data on all people known to have diabetes. Data are
collected prospectively from the adult and paediatric
secondary care diabetes services, all primary care cen›
tres within the district, and the diabetes eye service.
South Tees ethical committee granted approval for the
study.
Analyses were undertaken for the population of
people with diabetes as a whole and also for the popu›
lation subdivided into type 1 and type 2 diabetes. The
criteria for assigning type 1 diabetes were age 35 or less
at diagnosis and receiving insulin treatment at the start
of the study; the criteria for type 2 diabetes were age
over 35 at diagnosis or not taking insulin.
Death registration
All participants were registered by the Office for
National Statistics, and the date of death, causes of
death, and underlying cause of death were obtained
from death certificates for deaths occurring between 1
January 1994 and 31 December 1999 inclusive. The
inconsistent inclusion of diabetes on death certificates
creates problems when the underlying causes of death
in groups with and without diabetes are compared. To
correct for this a second underlying code for cause of
death was derived in all cases where the underlying
cause of death was diabetes—ICD›9 (international
classification of disease, ninth revision) code 250—by
removing diabetes from the list of causes and recoding
the underlying cause of death using ICD›9 rules.
Diabetes remained the underlying cause of death if it
was the only listed cause or if the immediate cause of
death was a short term metabolic complication, such as
hypoglycaemia or ketoacidosis.
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Comparison populations
Most studies of mortality related to diabetes use whole
population data as the comparator, despite the fact that
these data include people with diabetes, leading to bias
in the estimated effect. This bias can be considerable
when the prevalence of diabetes is high or the
standardised mortality ratio is large.12 Using local data
and removing people known to have diabetes from the
comparison group should minimise this bias.
The national comparison was made by using
population and mortality data for England and Wales,
1994›8.11 The local comparison was made with the
population of South Tees without known diabetes. This
population was derived by removing people known to
have diabetes from population figures for each year
obtained from the Tees Valley Joint Strategy Unit. Mor›
tality data were calculated by removing deaths of those
known to have diabetes from the full local mortality
data obtained from Office for National Statistics VS3
returns for South Tees, 1994›9, provided by Tees
Health Authority. Deaths were matched by year of
death, sex, five year age band, and cause of death (for
cause specific analyses) and were adjusted for the
decline in cohort numbers each year.
Material deprivation
Postcodes were used to allocate each participant to a
1991 census enumeration district, and a Townsend
score was generated for each district as a measure of
material deprivation.13 Participants were then grouped
into fifths by their score.
Analysis
Mortality was compared by using standardised
mortality ratios, with both the local and national popu›
lations described above as reference populations.
Calculation of confidence intervals for standardised
mortality ratios was based on the assumption that the
observed number of deaths is the mean of a Poisson
distribution, upper and lower 95% limits for which can
be obtained from published tables.14 Dividing these
limits by the expected number of deaths and multiply›
ing by 100 produces 95% confidence intervals for the
standardised mortality ratio. Similarly, 95% confidence
intervals for death rates standardised for age were esti›
mated by using the formula
observed death rate ± (1.96 × observed death rate/
’observed number of deaths).
Division by the death rate in the reference popula›
tion produced the corresponding confidence intervals
for the relative rates. The hypothesis that the risk of
dying during the study increased with worsening mate›
rial deprivation was tested by using ÷2 for linear trend
across the Townsend fifths.
A life table approach, based on published Office for
National Statistics data,15 16 was used to model the aver›
age life expectancy subject to either the death rates in
the study for people with type 2 diabetes or the average
death rates of England and Wales between 1994 and
1997. The reduction in life expectancy is then the life
expectancy calculated using the national death rates
minus the life expectancy calculated using the death
rates for people with diabetes.
Results
The cohort comprised 4842 people, giving 25 610
person years of follow up. Table 1 gives demographic
information. Only 22 subjects (0.45%) could not be
traced. Overall, 1205 participants died (24.9%)—659
men (24.6%) and 546 women (25.2%). Diabetes was
certified as the underlying cause of death for 9.4% of
men and 11.9% of women and was mentioned on the
death certificates of 45.4% of men and 50.6% of
women.
The data for all cause mortality (table 2) showed
excess deaths in patients with type 1 and type 2
diabetes in both sexes at all ages. Without exception,
the excess was higher in comparison with the national
population than with the local population without
diabetes, reflecting the higher than national mortality
in South Tees.11
This cohort had significant excess mortality
from cardiovascular disease, ischaemic heart disease,
cerebrovascular disease, and renal disease, but mor›
tality from neoplasia, respiratory disease, or accidents
and poisonings was not reduced (table 3). The risk
of death during the study in the most affluent
fifth with diabetes is in excess of that in the local
population without diabetes (table 4), and the risk
rises significantly with worsening material deprivation.
The life table analyses (figure) show that, poten›
tially, the life expectancy of both men and women
diagnosed as having type 2 diabetes at age 40 is
reduced by eight years relative to people without
diabetes. For those whose diagnosis was made after the
age of 50, women can expect to lose more years than
men, although the difference begins to narrow over the
age of 70. If the mortality of those aged under 80 had
been at national rates then 430 of the 1205 deaths
would have been avoided during the six years studied.
Table 1 Demographic data for the cohort at entry to study. Standardised prevalences
shown are directly standardised by age to the combined populations of England and
Wales, 1994›8
Age band (years)
and sex
Full cohort Type 1 diabetes Type 2 diabetes
No
Prevalence
(%) No
Prevalence
(%) No
Prevalence
(%)
0 to 19:
Female 65 0.16 62 0.16 3 0.01
Male 68 0.16 65 0.16 3 0.01
20 to 39:
Female 244 0.58 168 0.40 76 0.18
Male 292 0.69 221 0.52 71 0.17
40 to 59:
Female 560 1.63 96 0.28 464 1.35
Male 866 2.55 117 0.34 749 2.21
60 to 79:
Female 1046 4.04 9 0.03 1037 4.01
Male 1320 6.14 23 0.11 1297 6.03
80 and over:
Female 250 3.94 0 0 250 3.94
Male 131 5.16 0 0 131 5.16
All ages:
Female 2165 1.46 335 0.23 1830 1.24
Male 2677 1.89 426 0.30 2251 1.59
Prevalence standardised by age (%)
Female 1.53 0.23 1.31
Male 1.96 0.30 1.65
Combined 1.74 0.26 1.48
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Discussion
This study shows an excess mortality associated with
diabetes, even in an area with high background death
rates from cardiovascular disease. This excess mortality
is evident in all age groups, is most pronounced in
young people with type 1 diabetes, and is exacerbated
by material deprivation.
The large number of people studied, the almost
complete follow up, and the linkage to Office for
National Statistics records enabled us to draw
conclusions with confidence. Use of the local
population without diabetes as the comparison group
minimised bias in the estimates of relative mortality,
and the observed differences between local and
national comparisons emphasised the importance of
using local data for comparisons where possible. We
believe that our method of recoding the cause of death
allowed for more meaningful comparisons of cause
specific mortality between the groups with and without
diabetes.
Owing to the methods used to collate the register it
was not possible to perform capture›recapture analysis
to estimate ascertainment, but we are confident that the
data collection methods will have included most of the
local population known to have diabetes and that no
particular groups have been systematically excluded.
Our prevalence data (table 1) are comparable to previ›
ously reported prevalences of between 1% and 1.71%
in the United Kingdom.4 9 17 The definitions of type of
diabetes used are based on epidemiological rather
than clinical criteria but are similar to those used in
previous studies and are therefore suitable for
comparison.17 18 The relatively small number of deaths
in people aged under 40 result in wide confidence
intervals in some subgroups. The estimated standard›
ised mortality ratios are, however, similar to previous
estimates from the United States and are higher than
recent British estimates derived from selected
groups.19 20 The national comparison group includes
people with diabetes in the reference population,
which is a potential source of bias, and thus our results
will underestimate any excess in mortality.
The deprivation analyses rely on assigning an index
(the Townsend score) at a group level (the enumeration
district) and applying this to individuals, assuming that
all people in the group have similar deprivation
levels—an example of the “ecological fallacy.” However,
the methodology is well established,6–8 and bias from
misclassification between deprivation fifths would be
likely to mask any observed differences.
We believe that our study provides accurate and
comprehensive data on the excess mortality associated
with diabetes in the United Kingdom, which extends
and updates previous data that mainly relate to
Table 3 Cause specific mortality in cohort with diabetes compared with the local
population without diabetes, 1994›9
Cause (ICD›9 code) and sex
Type 1 diabetes Type 2 diabetes
No of
deaths
Standardised mortality
ratio (95% CI)*
No of
deaths
Standardised mortality
ratio (95% CI)*
Cardiovascular causes
(390›459):
Female 13 1365 (727 to 2334) 317 226 (202 to 253)
Male 21 536 (332 to 819) 370 196 (177 to 217)
Ischaemic heart disease
(410›414)
Female 9 1814 (829 to 3443) 200 268 (232 to 307)
Male 19 686 (413 to 1071) 273 223 (198 to 251)
Cerebrovascular disease
(430›438)
Female 3 1146 (236 to 3348) 80 191 (151 to 238)
Male 1 Not determined 67 180 (139 to 229)
Nephritis, nephrotic syndrome,
and nephrosis (580›589)
Female 1 Not determined 7 289 (116 to 596)
Male 1 Not determined 11 461 (230 to 826)
Neoplasia (140›239)
Female 2 Not determined 75 98 (77 to 123)
Male 0 Not determined 133 95 (79 to 112)
Respiratory disease (460›519)
Female 3 953 (197 to 2786) 61 98 (75 to 126)
Male 3 300 (62 to 878) 71 101 (79 to 127)
Accidents and poisonings
(E800›E999)
Female 0 Not determined 4 119 (32 to 304)
Male 1 Not determined 11 169 (84 to 302)
*Standardised mortality ratio shown only for categories in which three or more deaths occurred.
Table 2 All cause mortality in cohort with diabetes compared with the local population without diabetes, 1994›9, and the population
of England and Wales, 1994›8
Age at death
(years) and sex
Type 1 diabetes Type 2 diabetes
No of
deaths
Standardised mortality ratio (95% CI)*
No of
deaths
Standardised mortality ratio (95% CI)*
Compared with
local population
Compared with
England and Wales
Compared with
local population
Compared with
England and Wales
0›39:
Female 3 515 (106 to 1505) 526 (109 to 1538) 2 Not determined Not determined
Male 4 273 (75 to 700) 288 (79 to 738) 1 Not determined Not determined
40›59:
Female 11 620 (309 to 1109) 707 (353 to 1265) 24 256 (164 to 381) 298 (191 to 443)
Male 16 421 (241 to 684) 497 (284 to 806) 73 314 (246 to 395) 371 (291 to 466)
60›79:
Female 9 730 (334 to 1387) 848 (388 to 1610) 279 196 (173 to 220) 223 (197 to 250)
Male 9 172 (79 to 327) 202 (92 to 384) 411 141 (128 to 155) 164 (148 to 180)
80 and over:
Female 0 Not determined Not determined 218 125 (109 to 142) 126 (110 to 144)
Male 2 Not determined Not determined 143 109 (92 to 129) 116 (98 to 136)
All ages:
Female 23 641 (406 to 962) 722 (458 to 1083) 523 160 (147 to 174) 171 (156 to 186)
Male 31 294 (200 to 418) 340 (231 to 483) 628 141 (130 to 152) 159 (147 to 172)
*Standardised mortality ratio shown only for categories in which three or more deaths occurred.
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primary care,4 secondary care,9 21 or patients treated
with insulin.1 21 The study also shows that excess
mortality exists even against a background of high
levels of material deprivation and high mortality. More›
over, the most affluent fifth with diabetes still had a
higher mortality than the local population without
diabetes, and this excess mortality rises progressively
with worsening material deprivation. These data
extend the previous British data on the impact of
socioeconomic factors on mortality related to diabetes,
which described only patients treated in hospital or
selected middle aged patients.22 23 The excess mortality
extends even to those aged 80 and over, and the
observed increased death rate from cardiovascular
causes in all ages is not compensated for by a reduction
in other major causes of death.
Conclusions
In 1990 the St Vincent declaration recommended tar›
gets for care of patients with diabetes, including the
general goal of “a life approaching normal expectation
in quality and quantity.”24 Unfortunately, the results
from this study show that we are still far from this ideal.
The main cause of death in our cohort with
diabetes was ischaemic heart disease. The national
service framework for coronary heart disease has set
national targets and standards for the prevention and
treatment of coronary heart disease.25 The forthcom›
ing national service framework for diabetes will
provide a further opportunity to reduce the risk of
premature death in our patients. We believe that our
data will help to inform this process and that they
underline the importance of material deprivation.
Aggressive approaches to the management of cardio›
vascular risk factors could reduce the excess mortality
in people with diabetes.
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Health, for providing local population and mortality data; Keith
Elliott, principal information officer at Tees Valley Joint Strategy
Unit, for providing the Townsend score data; Pam Sherriff,
Elaine Hall, Dan Bowes, and all the other staff at the Diabetes
Centre for collating and maintaining the diabetes register, and
all the clinical staff in primary and secondary care without
whose cooperation the diabetes register would not be viable.
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Reductions in estimated life expectancy, by age at diagnosis of type
2 diabetes
What is already known on this topic
Mortality, mainly from cardiovascular disease, is increased in people with
diabetes, but this excess varies considerably by country and ethnic group
Previous British studies have reported no excess mortality in old age, a
reduction in deaths from non›cardiovascular causes, and that mortality
may be adversely affected by deprivation
What this study adds
Mortality is increased, across all ages, in an unselected population with
diabetes compared with the local population without diabetes, which
itself has high mortality
Most of the excess is from cardiovascular causes, but there are no
reductions in other causes of death
Mortality among people with diabetes is increased even in the most
affluent group, and this excess increases with worsening material
deprivation
Table 4 Deaths during the study, by Townsend fifth of material deprivation, types of diabetes combined, and median age (interquartile
range) at start of study
Fifth of material deprivation
÷2 for
trend1 (most deprived) 2 3 4 5 (most affluent)
Women:
No 446 443 432 394 412
P=0.004
Age 62 (50›71) 64 (51›74) 64 (51›74) 64 (52›73) 63 (47›73)
Deaths (% of fifth) 126 (28.3) 117 (26.4) 119 (27.5) 94 (23.9) 82 (19.9)
Relative death rate (95% CI)* 2.07 (1.71 to 2.43) 2.05 (1.68 to 2.43) 1.43 (1.17 to 1.68) 1.41 (1.12 to 1.69) 1.19 (0.93 to 1.45)
Men:
No 505 513 517 562 536
P<0.001
Age 60 (47›68) 62 (51›69) 62 (52›69) 62 (51›71) 60 (48›69)
Deaths (% of fifth) 140 (27.7) 144 (28.1) 136 (26.3) 127 (22.6) 102 (19.0)
Relative death rate (95% CI)* 2.49 (2.08 to 2.91) 2.41 (2.02 to 2.80) 2.05 (1.70 to 2.39) 1.64 (1.36 to 1.93) 1.47 (1.19 to 1.76)
Both sexes:
No 951 956 949 956 948
P<0.001
Age 61 (48›69) 63 (51›72) 63 (52›71) 62 (52›72) 61 (48›71)
Deaths (% of fifth) 266 (28.0) 261 (27.3) 255 (26.9) 221 (23.1) 184 (19.4)
Relative death rate (95% CI)* 2.34 (2.05 to 2.62) 2.24 (1.96 to 2.51) 1.70 (1.50 to 1.91) 1.52 (1.32 to 1.72) 1.30 (1.11 to 1.49)
*Study death rates, directly standardised by age to the combined male and female local population without diabetes, relative to the death rate of the same population.
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Do doctors position defibrillation paddles correctly?
Observational study
Richard M Heames, Daniel Sado, Charles D Deakin
Defibrillation is necessary to restore normal sinus
rhythm in a patient having a ventricular fibrillation
arrest. Each minute of delay in restoring sinus rhythm
increases mortality by 7›10%.1 Successful defibrillation
requires depolarisation of a critical mass of myocar›
dium, which is most likely to be achieved if the defibril›
lation paddles are correctly placed. Recent guidelines
from the European Resuscitation Council state that the
sternal paddle should be placed “below the right clavi›
cle in the mid›clavicular line” and that the apical
paddle should be placed “over the left lower ribs in the
mid/anterior axillary line.”2 The limited literature
available and our own observations suggest that these
anatomical positions are not adhered to during
defibrillation.3 We undertook an observational study to
assess paddle positioning during defibrillation.
Methods and results
We recruited 101 doctors of all grades and acute
specialties at Southampton General Hospital over a
period of two weeks, who were unprepared and
unaware of the nature of the study. They were shown
an anatomically accurate male resuscitation manikin
that they were told was in ventricular fibrillation. They
were asked to defibrillate the manikin, which required
the initial placement of sternal and apical defibrillation
pads on the chest wall, on to which were placed the
defibrillation paddles. The position of the centre of the
defibrillation pads was recorded by using a grid placed
over the chest wall. It was assumed that positions of the
pad centre and the paddle centre were anatomically
Anterior axillary line
Mid-axillary line
 ILCOR (2000)
Apical
paddle centre
ERC (1998)
Apical
paddle centre
Mid-clavicular line
Sternal
paddle centre
ERC (1998)
ILCOR (2000)
Anatomical position of the centre of apical and sternal defibrillation
paddles placed by 101 doctors. Positions recommended by the
European Resuscitation Council (ERC) and the International Liaison
Committee on Resuscitation (ILCOR) are also shown.
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